Loading...
•
Jun 30, 2023
Gyre Therapeutics Q2 2023 Earnings Report
Revenue and net profit increased compared to the same period last year.
Key Takeaways
Beijing Continent Pharmaceuticals Co., Ltd. reported an increase in revenue and net profit for the six months ended June 30, 2023. Revenue increased to RMB 379,265 thousands from RMB 312,673 thousands. Net profit increased to RMB 81,198 thousands from RMB 63,876 thousands.
Revenue from sales of pharmaceutical products reached RMB 379,265 thousands.
Net profit was RMB 81,198 thousands.
The company was approved as a High and New Technology Enterprise, entitling it to a preferential tax rate of 15%.
Shareholders approved to terminate the 2021 Stock Incentive Plan.
Historical Earnings Impact
Analyze how earnings announcements historically affect stock price performance
Avg. Return Before/After Earnings
Loading earnings performance data...
Loading earnings reaction data...